Join
Live feed
·
INSIDERFilingvia Quantisnow
Gemini Therapeutics Inc. logo

Bitterman Kevin sold $6,934,125 worth of shares (102,500 units at $67.65) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GMTX· Gemini Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GMTX (Gemini Therapeutics Inc.) and more on Quantisnow.